Basic Information
| RNALocate ID: | RLID-D:11000151 |
| RNA Symbol: | hsa-miR-146b-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-146b-5p |
| RNA ID: | miRBase:MIMAT0002809 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002323 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002324 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002325 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002960 | Exosome | Human milk | 28688106 |
| RLID:11002961 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002962 | Exosome | Brain tissue | 23382797 |
| RLID:11002963 | Exosome | Plasma | 23663360 |
| RLID:11002964 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002965 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002966 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11002967 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000478 | Microvesicle | Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-146b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-15576 |
| MNDR | hsa-miR-146b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-15577 |
| MNDR | hsa-miR-146b-5p | Oral squamous cell carcinoma | MNDR-E-MI-15578 |
| MNDR | hsa-miR-146b-5p | Medulloblastoma | MNDR-E-MI-15579 |
| MNDR | hsa-miR-146b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-15580 |
| MNDR | hsa-miR-146b-5p | Lymphoma | MNDR-E-MI-15581 |
| MNDR | hsa-miR-146b-5p | Cutaneous t cell lymphoma | MNDR-E-MI-15582 |
| MNDR | hsa-miR-146b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15583 |
| MNDR | hsa-miR-146b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-15584 |
| MNDR | hsa-miR-146b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15585 |
| MNDR | hsa-miR-146b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15586 |
| MNDR | hsa-miR-146b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-15587 |
| MNDR | hsa-miR-146b-5p | Triple negative sporadic breast cancer | MNDR-E-MI-15588 |
| MNDR | hsa-miR-146b-5p | Breast cancer luminal | MNDR-E-MI-15589 |
| MNDR | hsa-miR-146b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15590 |
| MNDR | hsa-miR-146b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-15591 |
| MNDR | hsa-miR-146b-5p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-15592 |
| MNDR | hsa-miR-146b-5p | Dermatomyositis | MNDR-E-MI-15593 |
| MNDR | hsa-miR-146b-5p | Prostate cancer | MNDR-E-MI-15594 |
| MNDR | hsa-miR-146b-5p | Hormone-refractory prostate carcinoma | MNDR-E-MI-15595 |
| MNDR | hsa-miR-146b-5p | Hirschsprung disease | MNDR-E-MI-15596 |
| MNDR | hsa-miR-146b-5p | Gastric cancer | MNDR-E-MI-15597 |
| MNDR | hsa-miR-146b-5p | Alzheimer disease | MNDR-E-MI-15598 |
| MNDR | hsa-miR-146b-5p | Intracranial aneurysm | MNDR-E-MI-15599 |
| MNDR | hsa-miR-146b-5p | Esophageal carcinoma | MNDR-E-MI-15600 |
| MNDR | hsa-miR-146b-5p | Dysautonomia familial | MNDR-E-MI-15601 |
| MNDR | hsa-miR-146b-5p | Myotonic dystrophy | MNDR-E-MI-15602 |
| MNDR | hsa-miR-146b-5p | Muscular dystrophy duchenne | MNDR-E-MI-15603 |
| MNDR | hsa-miR-146b-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-15604 |
| MNDR | hsa-miR-146b-5p | Leukemia | MNDR-E-MI-15605 |
| MNDR | hsa-miR-146b-5p | Huntington disease | MNDR-E-MI-15606 |
| MNDR | hsa-miR-146b-5p | Chorea | MNDR-E-MI-15607 |
| MNDR | hsa-miR-146b-5p | Cardiovascular disease | MNDR-E-MI-15608 |
| MNDR | hsa-miR-146b-5p | Brain cancer | MNDR-E-MI-15609 |
| MNDR | hsa-miR-146b-5p | Lung cancer | MNDR-E-MI-15610 |
| MNDR | hsa-miR-146b-5p | Temporal arteritis | MNDR-E-MI-15611 |
| MNDR | hsa-miR-146b-5p | Fragile x syndrome | MNDR-E-MI-15612 |
| MNDR | hsa-miR-146b-5p | Parkinson disease | MNDR-E-MI-15613 |
| MNDR | hsa-miR-146b-5p | Basal-like breast cancer | MNDR-E-MI-15614 |
| MNDR | hsa-miR-146b-5p | Thyroid neoplasms | MNDR-E-MI-15615 |
| MNDR | hsa-miR-146b-5p | Pancreatic cancer | MNDR-E-MI-15616 |
| MNDR | hsa-miR-146b-5p | Melanoma | MNDR-E-MI-15617 |
| MNDR | hsa-miR-146b-5p | Rectum adenocarcinoma | MNDR-E-MI-15618 |
| MNDR | hsa-miR-146b-5p | Nephroblastoma | MNDR-E-MI-15619 |
| MNDR | hsa-miR-146b-5p | Colon cancer | MNDR-E-MI-15620 |
| MNDR | hsa-miR-146b-5p | Ischemic attack transient | MNDR-E-MI-15621 |
| MNDR | hsa-miR-146b-5p | Colon adenocarcinoma | MNDR-E-MI-15622 |
| MNDR | hsa-miR-146b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15623 |
| MNDR | hsa-miR-146b-5p | Familial ovarian cancer | MNDR-E-MI-15624 |
| MNDR | hsa-miR-146b-5p | Prostate adenocarcinoma | MNDR-E-MI-15625 |
| MNDR | hsa-miR-146b-5p | Carcinoma ductal breast | MNDR-E-MI-15626 |
| MNDR | hsa-miR-146b-5p | Glioblastoma | MNDR-E-MI-15627 |
| MNDR | hsa-miR-146b-5p | Astrocytoma | MNDR-E-MI-15628 |
| MNDR | hsa-miR-146b-5p | Glioma | MNDR-E-MI-15629 |
| MNDR | hsa-miR-146b-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-15630 |
| MNDR | hsa-miR-146b-5p | Nemaline myopathy | MNDR-E-MI-15631 |
| MNDR | hsa-miR-146b-5p | Central nervous system lymphoma | MNDR-E-MI-15632 |
| MNDR | hsa-miR-146b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-15633 |
| MNDR | hsa-miR-146b-5p | Osteosarcoma | MNDR-E-MI-15634 |
| MNDR | hsa-miR-146b-5p | Inclusion body myositis | MNDR-E-MI-15635 |
| MNDR | hsa-miR-146b-5p | Meningioma | MNDR-E-MI-15636 |
| MNDR | hsa-miR-146b-5p | Cervical adenocarcinoma | MNDR-E-MI-15637 |
| MNDR | hsa-miR-146b-5p | Gastric adenocarcinoma | MNDR-E-MI-15638 |
| MNDR | hsa-miR-146b-5p | Lung squamous cell carcinoma | MNDR-E-MI-15639 |
| MNDR | hsa-miR-146b-5p | Non-small cell lung cancer | MNDR-E-MI-15640 |
| MNDR | hsa-miR-146b-5p | Thyroid carcinoma | MNDR-E-MI-15641 |
| MNDR | hsa-miR-146b-5p | Papillary thyroid carcinoma | MNDR-E-MI-15642 |
| MNDR | hsa-miR-146b-5p | Bladder urothelial carcinoma | MNDR-E-MI-15643 |
| MNDR | hsa-miR-146b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-15644 |
| MNDR | hsa-miR-146b-5p | Carcinoma renal cell | MNDR-E-MI-15645 |
| MNDR | hsa-miR-146b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15646 |
| MNDR | hsa-miR-146b-5p | Renal clear cell carcinoma | MNDR-E-MI-15647 |
| MNDR | hsa-miR-146b-5p | Cholangiocarcinoma | MNDR-E-MI-15648 |
| MNDR | hsa-miR-146b-5p | Gallbladder carcinoma | MNDR-E-MI-15649 |
| MNDR | hsa-miR-146b-5p | Myelofibrosis | MNDR-E-MI-15650 |
| MNDR | hsa-miR-146b-5p | Esophageal cancer | MNDR-E-MI-15651 |
| MNDR | hsa-miR-146b-5p | Oncocytoma | MNDR-E-MI-15652 |
| MNDR | hsa-miR-146b-5p | Lung small cell carcinoma | MNDR-E-MI-15653 |
| MNDR | hsa-miR-146b-5p | Stomach carcinoma | MNDR-E-MI-15654 |
| MNDR | hsa-miR-146b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-15655 |
| MNDR | hsa-miR-146b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-15656 |
| MNDR | hsa-miR-146b-5p | Acute t cell leukemia | MNDR-E-MI-15657 |
| MNDR | hsa-miR-146b-5p | Adenoma | MNDR-E-MI-15658 |
| MNDR | hsa-miR-146b-5p | Breast invasive carcinoma | MNDR-E-MI-15659 |
| MNDR | hsa-miR-146b-5p | Hepatocellular carcinoma | MNDR-E-MI-15660 |
| MNDR | hsa-miR-146b-5p | Familiar ovarian carcinoma | MNDR-E-MI-15661 |
| MNDR | hsa-miR-146b-5p | Rheumatoid arthritis | MNDR-E-MI-15662 |
| MNDR | hsa-miR-146b-5p | Malignant pleural mesothelioma | MNDR-E-MI-15663 |
| MNDR | hsa-miR-146b-5p | Retinoblastoma | MNDR-E-MI-15664 |
| MNDR | hsa-miR-146b-5p | Hodgkin lymphoma | MNDR-E-MI-15665 |
| MNDR | hsa-miR-146b-5p | Burkitt lymphoma | MNDR-E-MI-15666 |
| MNDR | hsa-miR-146b-5p | Tonsil cancer | MNDR-E-MI-15667 |
| MNDR | hsa-miR-146b-5p | Neuromyelitis optica | MNDR-E-MI-15668 |
| MNDR | hsa-miR-146b-5p | Psoriasis | MNDR-E-MI-15669 |
| MNDR | hsa-miR-146b-5p | Acute myelocytic leukemia | MNDR-E-MI-15670 |
| MNDR | hsa-miR-146b-5p | Colorectal cancer | MNDR-E-MI-15671 |
| MNDR | hsa-miR-146b-5p | Nasopharynx carcinoma | MNDR-E-MI-15672 |
| MNDR | hsa-miR-146b-5p | Multiple myeloma | MNDR-E-MI-15673 |
| MNDR | hsa-miR-146b-5p | Ependymoma | MNDR-E-MI-15674 |
| MNDR | hsa-miR-146b-5p | Nasopharyngeal cancer | MNDR-E-MI-15675 |
| MNDR | hsa-miR-146b-5p | Wounds and injuries | MNDR-E-MI-15676 |
| MNDR | hsa-miR-146b-5p | Polymyositis | MNDR-E-MI-15677 |
| MNDR | hsa-miR-146b-5p | Neoplasm residual | MNDR-E-MI-15678 |
| MNDR | hsa-miR-146b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-15679 |
| MNDR | hsa-miR-146b-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-15680 |
| MNDR | hsa-miR-146b-5p | Tubulovillous adenoma | MNDR-E-MI-15681 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AFAP1-AS1 | Homo sapiens | RR00052624 |
TOP